Summary of the technology
CD Genomics proprietary GenSeqTM Technology provides advanced multi-omics and bioinformatics service solutions for its global The Specialties of GenSeqTM customers who do research in laboratory. Equipped with the broadest industrial array of cutting-edge technologies and coupled with a group of experienced scientists and bioinformaticians, CD Genomics possesses significant contributions to genetic research.
Description of the technology
Our Sequenced Platforms include：
Genomics Transcriptomics Epigenomics Metagenomics Single-Cell Sequencing Immune Repertoire Sequencing FFPE Samples
CD Genomics delivers rapid, cost-effective and high-quality results that enable researchers to achieve scientific breakthroughs.
Our technologies and products have been validated through multiple partnerships with the world's leading diagnostic companies and testing laboratories. We are an international company with operations in Europe and the U.S.A.
Small and Medium Enterprise
About CD Genomics
Small and Medium Enterprise from United StatesCD Genomics
CD Genomics was established in 2004, we are aiming at providing the research community with high quality Next Generation Sequencing, high throughput microarray services. Due to the demand for our services has being increased; CD Genomics has already updated its technology platform to mainstream NGS and microarray instruments. At present, our senior bioinformaticians have ever viewed more than ten thousands of trace files and accumulated abundant experience with our Illumina HiSeq2000/2500, Illumia Miseq, Ion Torrent PGM, PacBio RS and ABI 3730/3730XL analyzers. We continue to work hard to offer you the same dependable services to pharmaceutical and biotech companies, as well as academia and government agencies for the purpose of satisfying all your sequencing or array needs.